What Excedr does

Excedr is a privately held equipment leasing company founded in 2011 and headquartered at 100 Pine Street in San Francisco, California. The company provides operating leases for scientific laboratory equipment, primarily serving biotech and life science startups ranging from seed-stage through Series C and beyond, as well as academic institutions and select life sciences enterprises. Rather than holding equipment inventory, Excedr operates a non-inventory sourcing model in which it finances and procures the specific instruments requested by each customer, functioning as a non-dilutive capital provider that converts large capital expenditures into predictable monthly operating expenses.

The product portfolio covers eight specialized equipment categories: analytical instruments, biotech & life sciences equipment, chromatography, clinical lab equipment, general lab equipment, lab safety equipment, microscopes, and spectroscopy. Lease terms run a minimum of 36 months (typically 3-5 years) with fixed monthly payments, and all leases include bundled service coverage for corrective repair and routine maintenance, eliminating separate annual service contracts. Pricing is custom-quoted per deal, based on equipment type, configuration, and term length. Excedr positions itself against traditional bank lenders with a faster approval process (days versus months for conventional institutions), with underwriting tailored to the cash flow profile of VC-backed and grant-funded life sciences companies rather than traditional revenue-based criteria.

Excedr generates revenue through recurring monthly lease payments on multi-year operating lease contracts. Distribution is primarily direct enterprise sales via the company website and consultation team, supported by a Partner Network that connects equipment vendors and service providers to the leasing customer base. Named customers include a long tail of early-stage biotech startups (Centivax, IgGenix, Zab Bio, KiraGen Bio, Novoron, Distributed Bio, Cartography Biosciences, Actio Biosciences, CTRL Therapeutics, Waypoint Bio, A-Alpha Bio, Talus Bio, Serotiny, Tempus, Sengine Precision Medicine, Tavros Therapeutics, Clinical Genomics) along with academic institutions (Stanford University, UC Berkeley) and enterprises (Abbott, Roche, Plug Power). The company also operates The Biotech Startups Podcast, eBooks and guides, and a biweekly newsletter as content marketing infrastructure targeting life sciences founders. Leadership comprises co-founder and CEO Jon Chee, with the company described as having 30+ years of combined equipment leasing experience.

Name

Excedr

Legal name

Excedr, Inc.

Website

https://excedr.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

Excedr is a San Francisco-based equipment leasing company founded in 2011 that provides operating leases for scientific lab instruments to biotech and life science startups, converting capital expenditures into predictable monthly payments.

Ownership category

akta.pro rank

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Technology or R&D, Operations, Personnel, Marketing or Sales

Revenue model

1. Equipment Leasing: Operating leases for scientific lab equipment with fixed monthly payments over 3-5 year terms. Customers can renew at discounted rates, purchase equipment, or conclude leases at term end.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Excedr provides operating leases for scientific and laboratory equipment to biotech, life sciences, and academic customers on flexible 3-5 year terms. Leases convert large equipment capital expenditures into predictable monthly operating expenses, with service and maintenance coverage bundled in. Equipment is sourced on demand across categories including analytical instruments, chromatography, microscopes, spectroscopy, and clinical, general, biotech, and safety lab equipment.

Product overview

Excedr offers a single unified offering: an operating lease program for scientific and laboratory equipment targeting biotech and life sciences startups. The core product provides flexible 3-5 year leases with maintenance coverage included, covering eight equipment categories (Analytical Instruments, Biotech & Life Sciences Equipment, Chromatography, Clinical Lab, General Lab, Lab Safety, Microscopes, and Spectroscopy). Excedr does not hold inventory; equipment is sourced on-demand once the lease is approved. The company complements its leasing platform with educational resources including eBooks/guides on equipment leasing and biotech startup operations, and produces The Biotech Startups Podcast as a content marketing asset. The portfolio functions as a single integrated leasing solution rather than a modular platform.

Differentiator

Problem solved

Functional benefit

Products and services

• Lab Equipment Leasing Program Core operating-lease program for scientific and laboratory equipment targeting biotech startups, life sciences firms, and academic institutions. Converts large equipment capital expenditures into fixed monthly payments over 3-5 year terms and includes service coverage for corrective repairs and preventive maintenance.
• Analytical Instruments Leasing Lease financing specifically for analytical instruments used in life sciences research and testing, under Excedr's 3-5 year operating lease structure.
• Biotech & Life Sciences Equipment Leasing Specialized leasing solutions for biotech and life sciences laboratory equipment, including instruments aligned to therapeutic and research workflows.
• Chromatography Equipment Leasing Lease options for chromatography systems and related analytical equipment used in biotech and life sciences laboratories.
• Clinical Lab Equipment Leasing Financing solutions for clinical laboratory instrumentation and equipment serving diagnostic, clinical research, and regulated lab environments.
• General Lab Equipment Leasing Broad category covering leasing options for standard laboratory equipment required by biotech, life sciences, and academic laboratories.
• Lab Safety Equipment Leasing Lease financing for laboratory safety equipment and instruments used in biotech and life sciences lab operations.
• Microscopes Leasing Equipment leasing for microscopy instruments including electron microscopes and optical systems used by research and biotech laboratories.
• Spectroscopy Equipment Leasing Lease solutions for spectroscopy equipment and analytical instruments used in life sciences and biotech research.
• Partner Network Strategic partner program connecting equipment vendors and service providers with Excedr's leasing customers, enabling deal sourcing and ecosystem referrals.

Quantifiable outcome

• Lease approval process takes days vs 3+ months for traditional financial institutions
• +2 more outcomes

Named customers25 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators1 record

Recent moves4 records

Expansion highlights3 records

Regional players

• Biolease: Biolease is a UK-based specialist in bioreactor and biotech equipment rental, directly comparable to Excedr's model of providing flexible operating leases for scientific instruments. Its geographic focus on UK/European biotech hubs makes it a regional rather than direct competitor.

Broad incumbents

• Thermo Fisher Scientific: Thermo Fisher is the largest scientific instrument manufacturer with a captive financing program and broad service offerings across analytical, clinical, and life sciences equipment. It serves enterprise customers like Abbott and Roche with bundled instrument-plus-financing solutions that overlap with Excedr's value proposition.
• Agilent Technologies: Agilent is a leading analytical instrument maker (chromatography, spectroscopy, mass spectrometry) with financial services and CrossLab service plans. Its instrument financing arm competes with Excedr's lease product for chromatography and spectroscopy equipment, particularly for enterprise accounts.
• Waters Corporation: Waters specializes in chromatography and mass spectrometry instruments and offers financing/leasing arrangements for its equipment. It competes with Excedr's chromatography leasing category and shares enterprise customers in pharmaceutical and biotech segments.
• Bruker Corporation: Bruker manufactures high-end scientific instruments across microscopy, spectroscopy, and analytical categories. It competes with Excedr's microscopy and spectroscopy leasing offerings and serves overlapping life sciences and biotech customers.
• Danaher Corporation: Danaher owns Beckman Coulter, Leica Microsystems, Molecular Devices, and other life sciences instrument brands. Its operating companies compete with Excedr across multiple equipment categories and offer bundled financing, service, and consumables that rival independent lessors.
• Bio-Rad Laboratories: Bio-Rad is a clinical and life sciences instrument and consumables manufacturer serving biotech, pharma, and academic customers similar to Excedr's target market. Its capital equipment lines overlap with Excedr's general lab and clinical lab leasing categories.
• Avantor: Avantor acquired VWR and is a major distributor of laboratory equipment and supplies to academic, biotech, and pharma customers. Its equipment offerings and customer base overlap with Excedr's, particularly in academic and enterprise segments where VWR's procurement relationships matter.
• Sartorius AG: Sartorius is a leading bioprocessing and lab equipment manufacturer serving biotech and pharmaceutical customers, overlapping with Excedr's biotech and life sciences equipment categories. Its product financing programs compete with Excedr's leases for bioprocessing instrumentation.

Direct peers

• Med One Capital: Med One Capital leases medical and capital equipment to healthcare and life sciences customers through a no-inventory operating lease model similar to Excedr's. While focused on medical devices, its lease structure and customer-financing approach make it a direct comparable in adjacent equipment categories.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/excedrinc
• YouTubeyoutube.com/channel/UCOWTf-uu1MdBN7QftBxOn9w
• Facebookfacebook.com/excedr
• LinkedInlinkedin.com/company/excedr
• Instagraminstagram.com/excedr_inc

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Excedr